LORNA BARTE: Open Payments
NPI 1154376762 · CAMARILLO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,386 in 342 payments from 18 companies in 2025. Trend: 2023 $3,501 · 2024 $4,730 · 2025 $6,386
Food & beverage: $6,304Education: $82
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 66 | $1,295 |
| Lundbeck LLC | 41 | $774 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 35 | $667 |
| Teva Pharmaceuticals USA, Inc. | 34 | $619 |
| Vanda Pharmaceuticals Inc. | 25 | $584 |
| Otsuka America Pharmaceutical, Inc. | 32 | $514 |
| ABBVIE INC. | 34 | $505 |
| E.R. Squibb & Sons, L.L.C. | 20 | $424 |
| Axsome Therapeutics, Inc. | 15 | $256 |
| Alkermes, Inc. | 14 | $223 |
Products named: INGREZZA, REXULTI, CAPLYTA, VRAYLAR, FANAPT, ABILIFY ASIMTUFII, COBENFY, UZEDY.
Industry payments across CA — which companies pay providers there.
